998 related articles for article (PubMed ID: 9231802)
1. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
[TBL] [Abstract][Full Text] [Related]
2. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
[TBL] [Abstract][Full Text] [Related]
3. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
4. Disruption of hypothalamic-pituitary-adrenocortical system in transgenic mice expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: effects on T cell trafficking and T cell responsiveness during postnatal development.
Morale MC; Batticane N; Gallo F; Barden N; Marchetti B
Endocrinology; 1995 Sep; 136(9):3949-60. PubMed ID: 7649104
[TBL] [Abstract][Full Text] [Related]
5. Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level.
Droste SK; Chandramohan Y; Hill LE; Linthorst AC; Reul JM
Neuroendocrinology; 2007; 86(1):26-37. PubMed ID: 17595533
[TBL] [Abstract][Full Text] [Related]
6. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
7. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses.
Houshyar H; Galigniana MD; Pratt WB; Woods JH
J Neuroendocrinol; 2001 Oct; 13(10):875-86. PubMed ID: 11679056
[TBL] [Abstract][Full Text] [Related]
8. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor.
Barden N; Stec IS; Montkowski A; Holsboer F; Reul JM
Neuroendocrinology; 1997 Sep; 66(3):212-20. PubMed ID: 9380279
[TBL] [Abstract][Full Text] [Related]
9. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein.
Dayanithi G; Antoni FA
Endocrinology; 1989 Jul; 125(1):308-13. PubMed ID: 2544406
[TBL] [Abstract][Full Text] [Related]
10. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences.
Schmidt MV; Sterlemann V; Wagner K; Niederleitner B; Ganea K; Liebl C; Deussing JM; Berger S; Schütz G; Holsboer F; Müller MB
Endocrinology; 2009 Jun; 150(6):2709-16. PubMed ID: 19213843
[TBL] [Abstract][Full Text] [Related]
11. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
13. Increased vasopressinergic activity as a possible compensatory mechanism for a normal hypothalamic-pituitary-adrenal axis response to stress in BALB/c nude mice.
Spinedi E; Hadid R; Gaillard RC
Neuroendocrinology; 1997 Oct; 66(4):287-93. PubMed ID: 9349663
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
[TBL] [Abstract][Full Text] [Related]
15. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS
Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075
[TBL] [Abstract][Full Text] [Related]
16. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
Spencer RL; Kim PJ; Kalman BA; Cole MA
Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term voluntary exercise on the mouse hypothalamic-pituitary-adrenocortical axis.
Droste SK; Gesing A; Ulbricht S; Müller MB; Linthorst AC; Reul JM
Endocrinology; 2003 Jul; 144(7):3012-23. PubMed ID: 12810557
[TBL] [Abstract][Full Text] [Related]
18. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
19. Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age.
Cizza G; Calogero AE; Brady LS; Bagdy G; Bergamini E; Blackman MR; Chrousos GP; Gold PW
Endocrinology; 1994 Apr; 134(4):1611-20. PubMed ID: 8137722
[TBL] [Abstract][Full Text] [Related]
20. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity.
Chan O; Inouye K; Vranic M; Matthews SG
Endocrinology; 2002 May; 143(5):1761-8. PubMed ID: 11956158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
